NCT05700617View on ClinicalTrials.gov

Cardiac Power Output in Cardiogenic Shock Patients

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Heart FailureCardiogenic Shock
Interventions
DRUG

1:1 Randomization to receive milrinone

Randomized to receive either inotropic agent: milrinone or no agent

Trial Locations (1)

60637

RECRUITING

The University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER